Gene therapy experiments in mice reveal that a protein that is a "clotting-contributor" in hemophila B is not needed in hemophilia A.
Nationwide Children's Hospital HTC staff, design experts and Ohio State University students devise creative distraction tool.
“Hot Topics in Hemophilia Nursing” is part of the online series, Clinical Advances in Hemophilia: Management for Life.
New tools help providers document even small health improvements in patients.
Researchers at UNC at Chapel Hill School of Medicine say discovery may have application to hemophilia.
“Hemophilia Updates: Incorporating New Concepts Into Practice” is the latest educational opportunity to become available from Medscape.
Gilead's Epclusa® shows high cure rates in people with and without liver cirrhosis.
Get your forms in by Friday, July 22.
New drug is the first recombinant single-chain therapy. Its long-lasting action may allow some patients to infuse twice weekly.
MASAC Document #242 is a valuable resource for understanding supply of clotting factor concentrate doses for home use by individuals with bleeding disorders.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car